| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Q-VD-OPH | 1135695-98-5 | sc-222230 | 5 mg | $782.00 | 5 | |
By preventing caspase activation, Q-VD-OPh could stall the apoptotic process, resulting in decreased presence of apoptotic markers in myeloid cells. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib might suppress the tyrosine kinase-mediated signaling cascade, leading to a decreased transcriptional activity of genes encoding apoptotic markers in myeloid cells. | ||||||
ABT 737 | 852808-04-9 | sc-207242 | 2.5 mg | $200.00 | 54 | |
ABT-737 may lead to increased apoptosis of myeloid cells by antagonizing anti-apoptotic proteins, but paradoxically, this could result in a short-term decrease in apoptotic marker presence as cells are rapidly cleared. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
By inhibiting autophagy, 3-Methyladenine could prevent the degradation of intracellular components, including apoptotic markers, thus maintaining their levels in myeloid cells. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide can downregulate the expression of TNF-α, potentially leading to a decreased stimulus for apoptosis and thus lower levels of apoptotic markers in myeloid cells. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin may downregulate the expression of genes involved in apoptosis by inhibiting the transcription factor NF-κB, resulting in decreased levels of apoptotic markers in myeloid cells. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK pathway inhibitor, SP600125 could reduce the stress-induced apoptotic response, consequently decreasing the levels of apoptotic markers in myeloid cells. | ||||||
caspase-9 inhibitor I | 210345-04-3 | sc-3085 sc-3085A | 1 mg 5 mg | $408.00 $1734.00 | 33 | |
Z-LEHD-FMK may prevent the mitochondrial pathway of apoptosis by inhibiting caspase-9 activation, which could result in reduced cleavage of apoptotic markers in myeloid cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059, by inhibiting MEK1/2, might lower ERK pathway signaling, leading to diminished transcriptional activation of genes related to apoptosis and thereby lower expression of apoptotic markers in myeloid cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 might decrease the activation of the PI3K/Akt pathway, which is known to promote cell survival, potentially resulting in downregulated expression of survival signals and increased expression of apoptotic markers in myeloid cells. | ||||||